These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5355958)

  • 21. Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients.
    Chandorkar AG; Burte NP; Jadhav JH; Gade RK; Bulakh PM; Tayshete SN; Kale VM
    Indian J Lepr; 1984; 56(2):264-8. PubMed ID: 6548496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Re-evaluation of anti-Hansenian chemotherapy by long-term study and by experimental and pharmacokinetic criteria].
    Carayon A
    Acta Leprol; 1980; (79):55-65. PubMed ID: 6794334
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sulfones in modern therapy of leprosy].
    MARIANO J
    Arq Min Leprol; 1953 Jan; 13(1):50-3. PubMed ID: 13115261
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on sulfone resistance in leprosy. I. Detection of cases.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1966; 34(4):375-90. PubMed ID: 6006069
    [No Abstract]   [Full Text] [Related]  

  • 25. [Supidimide, a non-teratogenic thalidomide analog for the treatment of leprosy reaction?].
    Sheskin J; Mückter H; Frankus E
    Hautarzt; 1983 Apr; 34(4):168-70. PubMed ID: 6853166
    [No Abstract]   [Full Text] [Related]  

  • 26. Steroid therapy and leprosy.
    Ramu G
    Indian J Lepr; 1996; 68(2):182-3. PubMed ID: 8835589
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug-induced pathomorphosis of skin lesions in leprosy].
    Vishnevetskiĭ FE
    Arkh Patol; 1971; 33(9):70-7. PubMed ID: 4336757
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
    [No Abstract]   [Full Text] [Related]  

  • 29. Further observations on streptomycin combined with sulfones in relapsed lepromatous leprosy.
    Hastings RC; Trautman JR; Mansfield RE
    Int J Lepr Other Mycobact Dis; 1969; 37(2):130-4. PubMed ID: 5389014
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of leprosy with diucifon].
    Goloshchapov NM; Steklovskiĭ VK; Filipskikh TP; Khromova EB
    Vestn Dermatol Venerol; 1983 Apr; (4):67-71. PubMed ID: 6868818
    [No Abstract]   [Full Text] [Related]  

  • 31. Supplies of thalidomide for use in leprosy.
    Loretti A; Barchi E
    Lepr Rev; 1986 Mar; 57(1):76-7. PubMed ID: 3702585
    [No Abstract]   [Full Text] [Related]  

  • 32. [Present-day specific therapeutic drugs for leprosy].
    Languillon J
    Med Trop (Mars); 1966; 26():Suppl 26:131+. PubMed ID: 4864601
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapy of leprosy with sulfonamides. Emphasis on the use of weekly doses.
    Opromolla DV
    Int J Lepr Other Mycobact Dis; 1971; 39(2):467-70. PubMed ID: 4948085
    [No Abstract]   [Full Text] [Related]  

  • 34. Length of continued treatment of an inactive case of leprosy.
    Dharmendra
    Lepr India; 1976 Jul; 48(3):212-6. PubMed ID: 1022967
    [No Abstract]   [Full Text] [Related]  

  • 35. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unsatisfactory results with thalidomide as a specific treatment for leprosy.
    Sheskin J; Sagher F; Dorfman M; Schrader-Beielstein HW
    Isr J Med Sci; 1968; 4(4):901-4. PubMed ID: 5710961
    [No Abstract]   [Full Text] [Related]  

  • 37. [Control of leprosy: fantasies and possibilities].
    Browne SG
    Acta Leprol; 1980; (81):27-33. PubMed ID: 6785980
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thalidomide in leprosy reactions].
    Netto LS
    Rev Bras Med; 1967 Sep; 24(9):760-3. PubMed ID: 5618212
    [No Abstract]   [Full Text] [Related]  

  • 39. The promin treatment of leprosy. A progress report.
    Faget GH; Pogge RC; Johansen FA; Dinan JF; Prejean BM; Eccles CG
    Int J Lepr Other Mycobact Dis; 1966; 34(3):298-310. PubMed ID: 5950351
    [No Abstract]   [Full Text] [Related]  

  • 40. Acedapsone in leprosy treatment: trial in 68 active cases in Micronesia.
    Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC
    Int J Lepr Other Mycobact Dis; 1972; 40(1):48-52. PubMed ID: 4672994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.